Overview of Botriomycoma in Children with a Central Line: Epidemiology, Risk Factors, Treatments
Condition(s) studied
Study summary
Botriomycomas are frequent benign tumors in children. Their appearance on the central catheter orifice is a known event in clinical practice, but one that has been little studied. This lesion could lead to changes in pathways and an increase in the number of sepsis events, which would promote thrombosis and thus depletion of venous capital in patients who have been dependent on a central line for many years.
This study is a pilot study which will enable us to better identify the risk factors for the development of such a tumour, and to take stock of the different treatments used and their respective efficacy.
Eligibility
Primary outcome measure(s)
- Appearance of Botryomycoma — From first diagnosis through a follow-up period of 2 years.
genetic characteristics (origin, phototype), local factors (mechanical, infectious), and general factors (history of sepsis). - Recurrence of Botryomycoma — From first diagnosis through a follow-up period of 2 years.
analyze risk factors for recurrence and evolution under different treatments.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Hôpital Mère-Enfant | Bron | France |
More Hospices Civils de Lyon trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06708689 on ClinicalTrials.gov ↗ ← All trials in France